Tyrosine Hydroxylase (Ab 31) Antibody

Product Specifications

Background

Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the synthesis of the neurotransmitter dopamine and other catecholamines. TH functions as a tetramer, with each subunit composed of a regulatory and catalytic domain, and exists in several different isoforms . This enzyme is required for embryonic development since TH knockout mice die before or at birth . Levels of transcription, translation and posttranslational modification regulate TH activity. The amino-terminal regulatory domain contains three serine residues: Ser9, Ser31 and Ser40. Phosphorylation at Ser40 by PKA positively regulates the catalytic activity of TH . Phosphorylation at Ser31 by CDK5 also increases the catalytic activity of TH through stabilization of TH protein levels.

NCBI Gene ID

7054

Swiss Prot

P07101

Accession Number

NP_954986.2

Host

Rabbit

Reactivity

Mouse, Rat

Immunogen

Tyrosine Hydroxylase (Ab-31) antibody was raised against a peptide sequence around aa.29~33 (V-T-S-P-R) derived from Mouse Tyrosine Hydroxylase.

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Neuroscience

Purification

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

Concentration

1 mg/mL

Buffer

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store antibody at -20˚ C for up to one year.

Calculated Molecular Weight

55 - 60 kDa

Specificity

This antibody detects endogenous levels of total Tyrosine Hydroxylase protein.

Applications Notes

Western Blot: 1:500~1:1000

Symbol

NCBI Official Name

Tyrosine hydroxylase

NCBI Organism

This antibody was raised against a peptide sequence around aa.29~33 (V-T-S-P-R) derived from Mouse Tyrosine Hydroxylase.

Background Reference 01

Kumer, S. C. and Vrana, K. E. (1996) J Neurochem 67, 443-62. Bodeau-Pean, S. et al. (1999) J Biol Chem 274, 3469-75. Kobayashi, K. et al. (1995) J Biol Chem 270, 27235-43. Lew, J. Y. et al. (1999) Mol Pharmacol 55, 202-9. Vie, A. et al. (1999) J Biol Chem 274, 16788-95. Lindgren, N. et al. (2000) J Neurochem 74, 2470-7. Moy, L. Y. and Tsai, L. H. (2004) J Biol Chem 279, 54487-93. Lehmann, I. T. et al. (2006) J Biol Chem 281, 17644-51. Saraf, A. et al. (2007) J Biol Chem 282, 573-80.